<DOC>
	<DOCNO>NCT00198536</DOCNO>
	<brief_summary>The purpose study determine whether ecabet ophthalmic solution effective treatment dry eye syndrome</brief_summary>
	<brief_title>Efficacy Safety Study Ecabet Ophthalmic Solution Treating Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Ecabet</mesh_term>
	<criteria>Agree avoid systemic &amp; topical ophthalmic med &amp; disallow med Have best correct visual acuity ( BCVA ) 20/40 pinhole good eye Diagnosis moderate dry eye syndrome Uncontrolled ocular systemic disease could interfere study Diagnosis Sjogren 's syndrome , lacrimal obstruction , reflex , lidrelated contact lensrelated dry eye syndrome ( DES ) ; significant anterior blepharitis meibomianitis Contraindications hypersensitivity use study med component Wear contact lenses Secondary dry eye surgery Eye surgery ( include laser ) within 6 month Use systemic topical ophthalmic med within 14 day Punctal plug one eyes place &lt; 45 day Permanent occlusion lacrimal puncta</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>